Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies
Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies
Recruiting · NCT04114136 · Registry updated 2026-06-23Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies | Digestive System Diseases, Digestive System Neoplasms, Head and Neck Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, adenocarcinoma, carcinoma, epithelial neoplasm, esophageal adenocarcinoma, gastric adenocarcinoma, head and neck squamous cell carcinoma, hepatocellular carcinoma, liver disorder, melanocytic neoplasm, melanoma, neoplasm, neuroendocrine neoplasm, non-small cell lung carcinoma, primitive neuroectodermal tumor, skin disorder, skin neoplasm, squamous cell carcinoma | Recruiting | Phase 2 | 2026-06-23 | NCT04114136 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Dan Zandberg | 4 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| UPMC Hillman Cancer Center | Pittsburgh | United States | 330 |